Arcadia Biosciences, Inc.
RKDA
$3.15
$0.155.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 21.25% | -1.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 21.25% | -1.32% | |||
| Cost of Revenue | 22.14% | -1.87% | |||
| Gross Profit | 20.08% | -0.58% | |||
| SG&A Expenses | 22.15% | -34.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.15% | -27.57% | |||
| Operating Income | -23.03% | 42.59% | |||
| Income Before Tax | -271.53% | 164.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -271.53% | 164.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -271.53% | 163.95% | |||
| EBIT | -23.03% | 42.59% | |||
| EBITDA | -23.12% | 42.63% | |||
| EPS Basic | -271.40% | 163.90% | |||
| Normalized Basic EPS | -742.48% | 121.89% | |||
| EPS Diluted | -271.64% | 163.81% | |||
| Normalized Diluted EPS | -437.74% | 121.89% | |||
| Average Basic Shares Outstanding | 0.07% | 0.08% | |||
| Average Diluted Shares Outstanding | 90.35% | 0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||